Wentong Fang

9PUBLICATIONS
8CO-AUTHORS
Molecular targetsTime-series analysisPredictive and prognostic markersTumour immunologyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 16, 2025
Advances and challenges of estrogen receptor-targeted agents in breast cancer.

Jie Hu, Songyang Zhong, Huayu Sun

|Apr 02, 2022
Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation.

Di Wu, Jianxiang Xie, Huizhen Dai

|Nov 15, 2021
ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer.

Wentong Fang, Chengheng Liao, Rachel Shi

|Feb 11, 2021
CD8+ T-cell percentage increases in diffuse large B-cell lymphoma patients receiving mannatide combined with standard regimens.

Min Wang, Biao Wang, Wentong Fang

|Oct 26, 2020
DEC2 Serves as Potential Tumor Suppressor in Breast Carcinoma.

Wentong Fang, Qian Li, Min Wang

Pageof 2